Gilead is committed to helping improve the lives of people around the world by bringing forward medicines
that prevent, treat and cure devastating diseases.
Below listed the apporved products in China:

Hepatitis C

Sovaldi®

sofosbuvir 400 mg

Harvoni®

ledipasvir 90 mg/sofosbuvir 400 mg*

Epclusa®

sofosbuvir 400 mg/velpatasvir 100 mg*

Vosevi®

sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg tablets*

Chronic Hepatitis B

Vemlidy®

tenofovir alafenamide 25 mg*

HIV

Genvoya®

elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir alafenamide 10 mg*

Descovy®

emtricitabine 200 mg/tenofovir alafenamide 25 mg For HIV treatment and HIV PrEP

Biktarvy®

bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg*

Truvada®

emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg For HIV treatment* and HIV PrEP

Sunlenca®

lenacapavir injection 463.5 mg/1.5 mL lenacapavir tablets 300 mg

Invasive Fungal Disease

AmBisome®

amphotericin b liposome for injection 50 mg/vial*

Breast Cancer

Trodelvy®

sacituzumab govitecan-hziy 180 mg for injection

*These drugs are included in the China National Reimbursement Drug List (NRDL).